Summary
The Gladden Longevity Podcast explores the dolphin research behind C15:0 with Dr. Stephanie Venn-Watson. The discussion covers how marine biology research yielded insights into human longevity, the metabolic pathways C15:0 activates, and its potential role in healthspan extension. The episode places C15:0 in the broader context of longevity interventions.
Key Points
- Dolphin health research revealed C15:0 as a key longevity biomarker
- C15:0 activates metabolic pathways associated with healthy aging and disease prevention
- The discovery adds to the growing toolkit of longevity interventions
- Marine biology provides a unique and underexplored model for nutritional science
- Fatty15 translates the dolphin discovery into an accessible human supplement
Key Moments
C15:0 as a longevity intervention
The conversation places C15:0 in the context of longevity interventions, exploring how this fatty acid supports healthy aging pathways.
"to look at thousands of small molecules in their fish and their blood. And that's when we found about 100 molecules that predicted the healthiest aging dolphins. And among the top of those, Jeff and Steve, was C15. And so we discovered C15 as, gosh, here's a fatty acid, odd chain saturated fat in the dolphins that if higher in their fish and their bodies, they were less likely to develop these aging associated conditions."
